Relationship between Stent Malapposition and Incomplete Neointimal Coverage after Drug-Eluting Stent Implantation

被引:6
|
作者
Kim, Byeong-Keuk [2 ]
Hong, Myeong-Ki [1 ,2 ]
Shin, Dong-Ho [2 ]
Kim, Jung-Sun [2 ]
Ko, Young-Guk [2 ]
Choi, Donghoon [2 ]
Jang, Yangsoo [2 ]
机构
[1] Yonsei Univ, Div Cardiol, Severance Cardiovasc Ctr, Severance Biomed Sci Inst,Coll Med, Seoul 120752, South Korea
[2] Severance Cardiovasc Hosp, Seoul, South Korea
关键词
OPTICAL COHERENCE TOMOGRAPHY; INTRAVASCULAR ULTRASOUND FINDINGS; TERM-FOLLOW-UP; THROMBOSIS; APPOSITION; PREDICTORS; RISK;
D O I
10.1111/j.1540-8183.2011.00706.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Using optical coherence tomography (OCT), we evaluated the relationship between malapposed and uncovered struts following implantation of drug-eluting stents (DESs). Methods: A total of 271 patients with 306 lesions who underwent DES implantation and follow-up OCT were included in the study. The lesions were grouped based on the presence of malapposition and then by the median value of the percentage of malapposed struts (1.3%) to produce 3 groups: lesions without malapposition (group I, n = 232) and those with percentage of malapposed struts <1.3% (group II, n = 37) or =1.3% (group III, n = 37). Percentages of malapposed and uncovered struts were calculated as percent ratio of malapposed or uncovered to total struts in the defined cross-sections, respectively. We compared percentage of uncovered struts in all analyzable struts and in the residual struts without malapposed segments among the 3 groups. Results: Group III showed a significantly larger percentage of uncovered struts among all the struts (group I, 3.7 +/- 6.4 vs. II, 5.5 +/- 5.6 vs. III, 17.6 +/- 15.9%, P < 0.001) and among residual struts without malapposed segments (3.7 +/- 6.4 vs. 5.2 +/- 5.7 vs. 15.0 +/- 14.4%, respectively, P < 0.001). There was a significant correlation between malapposed and uncovered struts in group III (r = 0.393, P = 0.016), but not in group II (r =-0.007, P = 0.965) among residual struts without malapposed segments. Conclusion: The percentage of uncovered DES struts was quite different depending on the presence and extent of malapposed struts. (J Interven Cardiol 2012;25:270277)
引用
收藏
页码:270 / 277
页数:8
相关论文
共 50 条
  • [31] Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis
    Hassan, Ayman K. M.
    Bergheanu, Sandrin C.
    Stijnen, Theo
    van der Hoeven, Bas L.
    Snoep, Jaapjan D.
    Plevier, Josepha W. M.
    Schalij, Martin J.
    Jukema, J. Wouter
    EUROPEAN HEART JOURNAL, 2010, 31 (10) : 1172 - 1180
  • [32] Clinical characteristics of stent fracture after drug-eluting stent implantation
    Yang, Tae-Hyun
    Kim, Seong-Man
    Kim, Dae-Kyung
    Kim, Doo-Il
    Kim, Dong-Soo
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 180M - 180M
  • [33] Angioscopic evaluation of neointimal coverage following treatment of in-stent restenosis: Comparison between brachytherapy, drug-eluting stent implantation and balloon angioplasty
    Kotani, J
    Awata, M
    Nanto, S
    Uematsu, M
    Morozumi, T
    Onishi, T
    Iida, O
    Ito, N
    Oshima, F
    Minamiguchi, H
    Akahori, H
    Nagata, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 12B - 13B
  • [34] Impact of Statin Treatment on Strut Coverage after Drug-Eluting Stent Implantation
    Suh, Yongsung
    Kim, Byeong-Keuk
    Shin, Dong-Ho
    Kim, Jung-Sun
    Ko, Young-Guk
    Choi, Donghoon
    Jang, Yangsoo
    Hong, Myeong-Ki
    YONSEI MEDICAL JOURNAL, 2015, 56 (01) : 45 - 52
  • [35] The association between incomplete stent apposition, multiple interstrut hollows, and in-stent thrombus formation in lesions after drug-eluting stent implantation
    Tada, T.
    Kadota, K.
    Habara, S.
    Tanaka, H.
    Fuku, Y.
    Goto, T.
    Mitsudo, K.
    EUROPEAN HEART JOURNAL, 2013, 34 : 545 - 546
  • [36] NEOINTIMAL PATTERN AND CLINICAL OUTCOME AFTER DRUG-ELUTING STENT IMPLANTATION: COMPARISON BETWEEN FIRST GENERATION AND SECOND GENERATION DRUG-ELUTING STENTS
    Yamamoto, Erika
    Higuma, Takumi
    Xing, Lei
    Minami, Yoshiyasu
    Bryniarski, Krzysztof
    Dai, Jiannan
    Zanchin, Thomas
    Sugiyama, Tomoyo
    Wang, Zhao
    Aguirre, Aaron
    Lee, Hang
    Jang, Ik-Kyung
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1063 - 1063
  • [37] The Impact of Drug-eluting Stent Induced Coronary Endothelial Dysfunction on Neointimal Hyperplasia 9 Months After Stent Implantation
    Tamaru, Hiroto
    Fujii, Kenichi
    Fukunaga, Masashi
    Imanaka, Takahiro
    Miki, Kojiro
    Horimatsu, Tetsuo
    Nishimura, Machiko
    Saita, Ten
    Ohyanagi, Mitsumasa
    Masuyama, Tohru
    CIRCULATION, 2013, 128 (22)
  • [38] Temporal Relation Between Clopidogrel Cessation and Stent Thrombosis After Drug-Eluting Stent Implantation
    Roy, Probal
    Bonello, Laurent
    Torguson, Rebecca
    Okabe, Teruo
    Pinto, Tina L.
    Steinberg, Daniel H.
    Kaneshige, Kimberly
    Xue, Zhenyi
    Satler, Lowell F.
    Kent, Kenneth M.
    Suddath, William O.
    Pichard, Augusto D.
    Lindsay, Joseph
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (06): : 801 - 805
  • [39] Drug-eluting balloons for restenosis after stent implantation
    Alfonso, Fernando
    Perez-Vizcayno, Maria J.
    LANCET, 2013, 381 (9865): : 431 - 433
  • [40] Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation
    Cook, Stephane
    Eshtehardi, Parham
    Kalesan, Bindu
    Raeber, Lorenz
    Wenaweser, Peter
    Togni, Mario
    Moschovitis, Aris
    Vogel, Rolf
    Seiler, Christian
    Eberli, Franz R.
    Luescher, Thomas
    Meier, Bernhard
    Jueni, Peter
    Windecker, Stephan
    EUROPEAN HEART JOURNAL, 2012, 33 (11) : 1334 - 1343